Table 1.
Demographics and baseline characteristics of study population
| Parameter | ||
|---|---|---|
| Gender (n) |
male female |
16 34 |
| Laterality (n) |
right left |
28 22 |
| Age (years) | 68.8 ± 8.9 | |
| BCVA (LogMAR) | 0.57 ± 0.33 | |
| Lens state (n) |
phakic pseudophakic |
32 18 |
| iERM stage (n) |
stage 2 stage 3 stage 4 |
13 32 5 |
| Type of ME (n) |
MME CME Combined ME |
20 15 15 |
| CRT (µm) | 488.56 ± 106.7 | |
| ONL (µm) | 231.10 ± 78.7 | |
| EIFL (µm) | 145.44 ± 136.6 | |
| SRF (n) |
presence absence |
8 42 |
| CBA (n) |
presence absence |
5 45 |
| EZ (n) |
continuous disrupted |
14 36 |
| Treatment (n) |
Eye drops + parabulbous steroids + intravitreal steroids |
17 11 22 |
BCVA: best corrected visual acuity, iERM: idiopathic epiretinal membrane, ME: macular edema, MME: microcystic ME, CME: cystoid ME, CRT: central foveal thickness, ONL: outer nuclear layer thickness, EIFL: ectopic inner foveal layer thickness, SRF: subretinal fluid, CBA: central bouquet abnormalities, EZ: ellipsoid zone status